Study of dose-dependent metabolism of 5,5-diphenyl-hydantoin in the rat using new methodology for isolation and quantitation of metabolites in vivo and in vitro. 1971

N Gerber, and W L Weller, and R Lynn, and R E Rangno, and B J Sweetman, and M T Bush

UI MeSH Term Description Entries
D008297 Male Males
D008862 Microsomes, Liver Closed vesicles of fragmented endoplasmic reticulum created when liver cells or tissue are disrupted by homogenization. They may be smooth or rough. Liver Microsomes,Liver Microsome,Microsome, Liver
D010477 Perfusion Treatment process involving the injection of fluid into an organ or tissue. Perfusions
D010672 Phenytoin An anticonvulsant that is used to treat a wide variety of seizures. It is also an anti-arrhythmic and a muscle relaxant. The mechanism of therapeutic action is not clear, although several cellular actions have been described including effects on ion channels, active transport, and general membrane stabilization. The mechanism of its muscle relaxant effect appears to involve a reduction in the sensitivity of muscle spindles to stretch. Phenytoin has been proposed for several other therapeutic uses, but its use has been limited by its many adverse effects and interactions with other drugs. Diphenylhydantoin,Fenitoin,Phenhydan,5,5-Diphenylhydantoin,5,5-diphenylimidazolidine-2,4-dione,Antisacer,Difenin,Dihydan,Dilantin,Epamin,Epanutin,Hydantol,Phenytoin Sodium,Sodium Diphenylhydantoinate,Diphenylhydantoinate, Sodium
D002247 Carbon Isotopes Stable carbon atoms that have the same atomic number as the element carbon but differ in atomic weight. C-13 is a stable carbon isotope. Carbon Isotope,Isotope, Carbon,Isotopes, Carbon
D002849 Chromatography, Gas Fractionation of a vaporized sample as a consequence of partition between a mobile gaseous phase and a stationary phase held in a column. Two types are gas-solid chromatography, where the fixed phase is a solid, and gas-liquid, in which the stationary phase is a nonvolatile liquid supported on an inert solid matrix. Chromatography, Gas-Liquid,Gas Chromatography,Chromatographies, Gas,Chromatographies, Gas-Liquid,Chromatography, Gas Liquid,Gas Chromatographies,Gas-Liquid Chromatographies,Gas-Liquid Chromatography
D006207 Half-Life The time it takes for a substance (drug, radioactive nuclide, or other) to lose half of its pharmacologic, physiologic, or radiologic activity. Halflife,Half Life,Half-Lifes,Halflifes
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001646 Bile An emulsifying agent produced in the LIVER and secreted into the DUODENUM. Its composition includes BILE ACIDS AND SALTS; CHOLESTEROL; and ELECTROLYTES. It aids DIGESTION of fats in the duodenum. Biliary Sludge,Sludge, Biliary
D001711 Biotransformation The chemical alteration of an exogenous substance by or in a biological system. The alteration may inactivate the compound or it may result in the production of an active metabolite of an inactive parent compound. The alterations may be divided into METABOLIC DETOXICATION, PHASE I and METABOLIC DETOXICATION, PHASE II.

Related Publications

N Gerber, and W L Weller, and R Lynn, and R E Rangno, and B J Sweetman, and M T Bush
February 1976, The Journal of pharmacology and experimental therapeutics,
N Gerber, and W L Weller, and R Lynn, and R E Rangno, and B J Sweetman, and M T Bush
April 1963, Arzneimittel-Forschung,
N Gerber, and W L Weller, and R Lynn, and R E Rangno, and B J Sweetman, and M T Bush
January 1963, Helvetica physiologica et pharmacologica acta,
N Gerber, and W L Weller, and R Lynn, and R E Rangno, and B J Sweetman, and M T Bush
January 1993, Drug metabolism and disposition: the biological fate of chemicals,
N Gerber, and W L Weller, and R Lynn, and R E Rangno, and B J Sweetman, and M T Bush
August 1977, Biomedical mass spectrometry,
N Gerber, and W L Weller, and R Lynn, and R E Rangno, and B J Sweetman, and M T Bush
January 2009, Prostaglandins, leukotrienes, and essential fatty acids,
N Gerber, and W L Weller, and R Lynn, and R E Rangno, and B J Sweetman, and M T Bush
February 1986, The Journal of pharmacology and experimental therapeutics,
N Gerber, and W L Weller, and R Lynn, and R E Rangno, and B J Sweetman, and M T Bush
January 1980, Drug metabolism and disposition: the biological fate of chemicals,
N Gerber, and W L Weller, and R Lynn, and R E Rangno, and B J Sweetman, and M T Bush
July 2001, Brain research,
N Gerber, and W L Weller, and R Lynn, and R E Rangno, and B J Sweetman, and M T Bush
November 1987, Research communications in chemical pathology and pharmacology,
Copied contents to your clipboard!